NCT00002565View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 25, 1994

Primary Completion Date

February 5, 2007

Study Completion Date

February 5, 2007

Conditions

Lymphoma

Interventions

BIOLOGICAL

bleomycin sulfate

DRUG

CHOP regimen

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

idarubicin

DRUG

ifosfamide

DRUG

mesna

DRUG

methylprednisolone

DRUG

mitoxantrone hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (3)

5951

Clinica Alemana, Santiago

77030

University of Texas - MD Anderson Cancer Center, Houston

01224--010

Faculdade de Medicina do ABC, São Paulo

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00002565 - Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter